Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Clovis Oncology Inc (CLVSQ)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Clovis historical data, for real-time data please try another search
0.016 +0.000    +0.00%
10/07 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.010 - 0.017
Type:  Equity
Market:  United States
Clovis 0.016 +0.000 +0.00%

CLVSQ Recent Sentiments

 
User's sentiments regarding Clovis shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect CLVSQ shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Clovis.
Start Date Username Call Open Rate End Date Chg. %
Nov 02, 2023 Vitalij Suchina   0.016 Nov 30, 2023 @ 0.016 0.00%
Aug 08, 2023 احمد الاسمري   0.016 Nov 30, 2023 @ 0.016 0.00%
Aug 01, 2023 Rodrigo Sozo   0.016 Nov 30, 2023 @ 0.016 0.00%
Jul 18, 2023 sony waio   0.016 Nov 30, 2023 @ 0.016 0.00%
May 05, 2023 Irfan Çakmak   0.034 Nov 30, 2023 @ 0.016 -52.94%
May 01, 2023 jyotsna singhal   0.037 Nov 30, 2023 @ 0.016 -56.76%
May 01, 2023 Alessio Zanin   0.039 Nov 30, 2023 @ 0.016 -58.97%
Apr 18, 2023 Andreas Schatz   0.018 Nov 30, 2023 @ 0.016 -11.11%
Apr 06, 2023 David Morell   0.044 May 09, 2023 @ 0.041 -6.82%
Apr 06, 2023 אבי עסיס   0.045 May 09, 2023 @ 0.041 +8.89%
Apr 05, 2023 Виталий Сорокин   0.072 May 09, 2023 @ 0.041 -43.06%
Mar 20, 2023 Andreas Schatz   0.086 Apr 14, 2023 @ 0.025 -70.93%
Feb 08, 2023 Matteo Scarcello   0.110 Mar 03, 2023 @ 0.140 +27.27%
Feb 07, 2023 Andreas Schatz   0.118 Mar 03, 2023 @ 0.140 +18.64%
Feb 02, 2023 Sych Petr   0.115 Feb 06, 2023 @ 0.113 -1.74%
Jan 12, 2023 Carlos Marquez   0.140 Feb 03, 2023 @ 0.113 -19.29%
Jan 11, 2023 Gideon Strassmann   0.143 Feb 03, 2023 @ 0.113 -20.98%
Jan 11, 2023 Mirko Mazzacane   0.130 Feb 03, 2023 @ 0.113 -13.08%
Jan 11, 2023 Irfan Çakmak   0.098 Feb 03, 2023 @ 0.113 +15.31%
Jan 10, 2023 Vincent Senécal   0.060 Feb 03, 2023 @ 0.113 +88.33%
Jan 10, 2023 Sophie Cuendet   0.055 Feb 03, 2023 @ 0.113 -105.45%
Jan 09, 2023 Georges Strickaert   0.059 Jan 16, 2023 @ 0.150 +154.24%
Jan 09, 2023 Andreas Schatz   0.062 Feb 03, 2023 @ 0.113 +82.26%
Jan 09, 2023 John Wouters   0.050 Feb 03, 2023 @ 0.113 -126.00%
Dec 30, 2022 David Morell   0.052 Jan 20, 2023 @ 0.151 +190.38%
Dec 28, 2022 שמעון כהן   0.054 Jan 20, 2023 @ 0.151 +179.63%
Dec 21, 2022 Hakan Çakar   0.081 Jan 13, 2023 @ 0.150 +85.19%
Dec 21, 2022 Cfrlh Henriques   0.081 Jan 13, 2023 @ 0.150 -85.19%
Dec 21, 2022 jk k   0.081 Jan 13, 2023 @ 0.150 +85.19%
Dec 19, 2022 Necmettin Yılmaz   0.081 Dec 26, 2022 @ 0.062 +23.46%
Dec 16, 2022 Aliaksei Aliaksandrau   0.077 Dec 16, 2022 @ 0.077 0.00%
Dec 16, 2022 Wafa Majdoub   0.105 Dec 27, 2022 @ 0.062 -40.95%
Dec 15, 2022 Paky Paky   0.097 Jan 06, 2023 @ 0.050 -48.45%
Dec 14, 2022 Cruzeiro dos Santos   0.135 Dec 19, 2022 @ 0.079 +41.48%
Dec 14, 2022 Gastón Pietranera   0.141 Jan 06, 2023 @ 0.050 +64.54%
Dec 13, 2022 Ben van Wijmelbeke   0.134 Jan 06, 2023 @ 0.050 +62.69%
Dec 13, 2022 Hüseyin Yılmaz   0.160 Jan 06, 2023 @ 0.050 -68.75%
Dec 12, 2022 Antonio Mntlvo   0.189 Jan 06, 2023 @ 0.050 +73.54%
Dec 09, 2022 Alfred Rey   0.212 Dec 30, 2022 @ 0.053 +75.00%
Dec 07, 2022 Andreas Schatz   0.227 Dec 30, 2022 @ 0.053 -76.65%
Dec 06, 2022 Edward Shapiro   0.253 Dec 06, 2022 @ 0.250 +1.19%
Dec 06, 2022 jyotsna singhal   0.264 Dec 30, 2022 @ 0.053 -79.92%
Dec 05, 2022 Robbert Kuipers   0.300 Dec 30, 2022 @ 0.053 -82.33%
Dec 05, 2022 Robbert Kuipers   0.300 Dec 05, 2022 @ 0.300 0.00%
Dec 05, 2022 Christine Olivier   0.300 Dec 30, 2022 @ 0.053 -82.33%
Dec 05, 2022 Ömer Gündüz   0.305 Dec 08, 2022 @ 0.204 -33.11%
Nov 23, 2022 Miguel Ambrona Arnaiz   0.354 Dec 16, 2022 @ 0.080 -77.40%
Nov 22, 2022 mattia pittavino   0.340 Nov 22, 2022 @ 0.340 0.00%
Nov 21, 2022 Rodrigo Sozo   0.349 Dec 16, 2022 @ 0.080 -77.08%
Nov 21, 2022 menuha waks   0.347 Nov 28, 2022 @ 0.338 -2.59%
More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CLVSQ Price Commentary

Write your thoughts about Clovis Oncology Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Svetljo Svetljo
Svetljo Svetljo Nov 22, 2022 20:16
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any news ?
Reply
0 0
Report
Arminvest Net
Arminvest Net Jul 05, 2022 12:27
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
33 soon
Reply
2 0
Report
John Rollings
John Rollings Apr 20, 2022 14:54
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna SHOOT RIGHT UP !
Reply
1 0
Report
John Rollings
John Rollings Apr 20, 2022 14:46
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna *****!
Reply
1 0
Report
John Rollings
John Rollings Apr 20, 2022 14:44
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4 4/20/2022 BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its rst quarter 2022 nancial results on Wednesday, May 4, 2022, before the open of the US nancial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss the Company’s results in greater detail. The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days. Dial-in numbers for the conference call are as follows: US participants 888.440.4615, International participants 646.960.0682, conference ID: 2259685
Reply
1 0
Report
John Rollings
John Rollings Apr 11, 2022 19:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NOT LONG BEFORE PFIZER OR A SIMILAR BIG PHARMA SNAPS THIS UP AND SHARES WORTH 10 X WHAT THEY ARE NOW AT $2.48 IN MY OPINION DYOR Clovis Oncology’s Rubraca® (Rucaparib) Signicantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial 3/31/2022 https://s22.q4cdn.com/778348918/files/doc_news/Clovis-Oncologys-Rubraca-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-C16N4.pdf
Reply
1 0
Report
Co Co
Co Co Mar 24, 2021 21:40
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Clvs might be next gme apparently
Reply
1 0
Report
Co Co
Co Co Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Shouldnt be to quiet today
Reply
0 0
Report
L X Apurbo Vai
L X Apurbo Vai Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what
Reply
0 0
Report
Co Co
Co Co Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sorry my reply to an old comment
Reply
0 0
Report
Peter Gowler
Peter Gowler Feb 26, 2021 14:27
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
quite in here lol
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email